Who is sponsoring NCT00496574?

NCT00496574 is sponsored by Medical University of Lodz.

What drugs are being tested in NCT00496574?

Interventions: Novo Helisen Depot, Phostal.

What is the status of NCT00496574?

NCT00496574 is currently UNKNOWN.

Last reviewed 2013-02-06 · How we verify

Evaluation of Long-term Clinical Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma

NCT00496574 Phase 4 UNKNOWN

The aim of the study is to assess the effect of specific immunotherapy (SIT) to dust mites on clinical symptoms, reliever drugs usage, inhaled glucocorticosteroid usage, quality of life, lung function, bronchial hyperreactivity with methacholine, and presence and type of allergy after three years of SIT in children with asthma.

Details

Lead sponsor	Medical University of Lodz
Phase	Phase 4
Status	UNKNOWN
Enrolment	60
Start date	2006-05
Completion	2013-12

Conditions

Asthma

Interventions

Novo Helisen Depot, Phostal

Primary outcomes

clinical symptoms, reliever drugs usage, inhaled glucocorticosteroid usage, quality of life, lung function — baseline (first visit), 12 months (second visit), 24 months (third visit), 36 months (fourth visit)

Countries

Poland